NCT07521800Recruiting
Remote ECG Monitoring Post TAVI
Remote ECG Monitoring as a Diagnostic Tool for Therapeutic Strategies After Transcatheter Aortic Valve Replacement: Rationale and Design of the DRAGON-TAVI Trial.
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The DRAGON TAVI study is a multicenter, prospective, open, randomised trial, which will enrol 250 patients, randomized 1:1 to the study group (continuous 30-day ECG monitoring with visits triggered by ECG findings) and standard care (ie. control group, which will receive the standard post op 24-48h ECG monitoring and a regular follow-up visit with standard ECG within 30 days). The duration of the study is 12 months ± 1 month.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- Dec 2023
- Primary completion date
- Feb 2027
- Lead sponsor
- Medical University of Silesia
- Diseases
- Atrial fibrillation
- NCT number
- NCT07521800
What you commit to
- Study type: Interventional
- Planned participants: 250
- From Dec 2023 to the primary completion date, Feb 2027
- 4 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previously known conduction disturbances\*\*
- Ischaemic stroke, TIA, MI or heart surgery within 1 month before TAVI qualification
- Chronic immunosuppressive therapy
Other illness
- History of atrial fibrillation or atrial flutter
- Haemorrhagic stroke within 1 year before TAVI qualification
- Comorbidities (e.g. drug addiction, alcohol abuse, emotional/mental disorders) which do not allow safe participation in the study
Other
- Presence of: pacemaker, CRT-P, ICD, CRT-D before or after TAVI
Who the study is looking for
- Patient age over 18 years old
- Severe aortic stenosis
- Moderate or high cardiovascular risk based on current ESC Guidelines "Heart Team" qualification for TAVI
- Written informed consent of the patient for participation in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Division of Cardiology, Departement of Medical Science University of Turin, Città della Salute e Della Scienza Coordinator of this site? Confirm its status | Turin | Italy | Recruiting |
| Department of Invasive Cardiology, Medical University of Białystok, Bialystok, Poland Coordinator of this site? Confirm its status | Bialystok | Poland | Recruiting |
| Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland Coordinator of this site? Confirm its status | Katowice | Poland | Not yet recruiting |
| Medical University of Silesia Coordinator of this site? Confirm its status | Katowice | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.